vTv Therapeutics (VTVT) Shares Outstanding (2014 - 2026)

vTv Therapeutics has reported Shares Outstanding (Entity) for 13 years, with the latest figure at $12.4 million in Q1 2026.

• Quarterly Shares Outstanding (Entity) rose 88.51% year-over-year to $12.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $12.4 million (up 88.51% YoY) and the FY2025 annual result came in at $8.4 million, up 45.96% from the prior year.
• Shares Outstanding (Entity) climbed to $12.4 million in Q1 2026 per VTVT's latest filing, from $8.4 million in the prior quarter.
• Over five years, Shares Outstanding (Entity) peaked at $12.4 million in Q1 2026 and troughed at $1.7 million in Q1 2022.
• A 5-year average of $4.7 million and a median of $4.1 million in 2024 frame the typical range for Shares Outstanding (Entity).
• The sharpest annual moves came in 2023 and 2024: Shares Outstanding (Entity) changed 0.0% in 2023, then jumped 214.34% in 2024.
• Over 5 years, Shares Outstanding (Entity) stood at $2.0 million in 2022, then grew by 2.35% to $2.1 million in 2023, then soared by 176.79% to $5.8 million in 2024, then jumped by 45.96% to $8.4 million in 2025, then jumped by 47.32% to $12.4 million in 2026.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $12.4 million, $8.4 million, and $8.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.